Finance

Lists
Why is 539730 down 3,36%?
Dive Deeper
539730:BOM
Fredun Pharmaceuticals Ltd
1 459,00 INR
-3,36%
(-50,65) 1D
15-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539730...
Open
1 535,05 INR
High
1 535,05 INR
Low
1 420,10 INR
Mkt. cap
24,41 млд
Avg. vol.
18,64 миң
Volume
11,77 миң
P/E ratio
54,42
52-wk high
1 666,35 INR
52-wk low
454,05 INR
EPS
26,81 INR
Shares outstanding
3,99 млн
No. of employees
736
Open
1 535,05 INR
High
1 535,05 INR
Low
1 420,10 INR
Mkt. cap
24,41 млд
Avg. vol.
18,64 миң
Volume
11,77 миң
P/E ratio
54,42
52-wk high
1 666,35 INR
52-wk low
454,05 INR
EPS
26,81 INR
Shares outstanding
3,99 млн
No. of employees
736
News stories
From web sources and news partners
About Fredun Pharmaceuticals Ltd
CEO-
Employees736
Founded1987
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 13-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
2,28 млд / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,44 млд
1,60 млд
2,13 млд
2,28 млд
Cost of goods sold
1,09 млд
1,15 млд
1,60 млд
1,77 млд
Cost of revenue
1,09 млд
1,15 млд
1,60 млд
1,77 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82,99 млн
81,46 млн
484,22 млн
71,21 млн
Operating expense
163,40 млн
210,93 млн
270,90 млн
216,29 млн
Total operating expenses
1,25 млд
1,36 млд
1,87 млд
1,99 млд
Operating income
187,30 млн
235,55 млн
252,32 млн
286,78 млн
Other non operating income
17,06 млн
9,97 млн
-49,65 млн
4,92 млн
EBT including unusual items
127,05 млн
140,02 млн
112,48 млн
205,52 млн
EBT excluding unusual items
127,05 млн
140,02 млн
112,48 млн
205,52 млн
Income tax expense
32,74 млн
35,24 млн
53,02 млн
74,20 млн
Effective tax rate
25,77%
25,17%
47,14%
36,10%
Other operating expenses
61,48 млн
111,63 млн
-244,82 млн
109,37 млн
Net income
94,32 млн
104,78 млн
59,45 млн
131,32 млн
Net profit margin
6,57%
6,55%
2,80%
5,77%
Earnings per share
-
-
-
-
Interest and investment income
-
-
6,60 млн
-
Interest expense
-77,31 млн
-105,50 млн
-126,75 млн
-86,18 млн
Net interest expenses
-77,31 млн
-105,50 млн
-120,15 млн
-86,18 млн
Depreciation and amortization charges
18,93 млн
17,84 млн
31,50 млн
35,71 млн
EBITDA
203,86 млн
247,83 млн
272,79 млн
307,24 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору